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Abstract
SNP data has grown exponentially over the last two years, SNP database evolution has
matched this growth, as initial development of several independent SNP databases has
given way to one central SNP database, dbSNP. Other SNP databases have instead
evolved to complement this central database by providing gene speciﬁc focus and an
increased level of curation and analysis on subsets of data, derived from the central data
set. By contrast, human mutation data, which has been collected over many years, is still
stored in disparate sources, although moves are afoot to move to a similar central
database. These developments are timely, human mutation and polymorphism data both
hold complementary keys to a better understanding of how genes function and malfunction
in disease. The impending availability of a complete human genome presents us with an
ideal framework to integrate both these forms of data, as our understanding of the
mechanisms of disease increase, the full genomic context of variation may become
increasingly signiﬁcant. Copyright # 2001 John Wiley & Sons, Ltd.
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Introduction
As the sequencing of the human genome has drawn
into its ﬁnal stages, focus on human genetic variation
has come to the fore – mainly in the form of single
nucleotide polymorphisms (SNPs) – which offer to
revolutionise the way we study human genetics and
disease. For the geneticist, SNP markers are a key
research material for genetic association with heri-
table traits, but for those with a wider interest in
genomics and biology, the new SNP data is also a
valuable resource. The variation we see so far can tell
us many things about the functional parameters and
critical regions of a gene, protein, regulatory element
or genomic region. More speciﬁcally knowledge of
other forms of human variation such as human
mutation can tell us a great deal about the function
of genes and biological pathways by studying their
dysfunction in genetic disease.
SNPs are the commonest form of variation in the
genome, comparison of any two chromosomes will
generally reveal SNPs at 1.2 kb average intervals
across the genome [1]. SNPs as disease markers are
now the great hope of genetics, but this focus has
not always been so, despite their abundance in the
genome, without knowledge of genome sequence,
SNP identiﬁcation is a laborious process which has
made SNP availability limited. Instead geneticists
used more easily identiﬁed, but less plentiful,
tandem repeat sequences (microsatellites) as mark-
ers. These have been widely used for linkage
analysis of family based disease inheritance patterns
which because of family relatedness can extend over
many megabases. Such family based linkage scans
have been very successful in mapping mutations
causing single gene disorders or Mendelian traits,
but have been largely unsuccessful in detecting the
multiple genes responsible for common complex
diseases [12]. An alternative approach for mapping
complex disease genes is to use markers to detect
population based allelic association or linkage
disequilibrium between markers and disease alleles.
These associations can be very strong even where
the corresponding family linkage signal is weak or
absent. The drawback to this approach is that
population based association usually extends over
much shorter genomic distances anywhere between
5–100 kilobases [10]. Detection of this association
demands a massive increase in marker density with
more than 500 000 markers estimated to be needed
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compared to the 200–500 markers needed for a
family based linkage scan.
SNP markers are probably the only viable option
for these population based studies, but until very
recently demand has completely outstripped SNP
availability. Ambitious whole genome SNP associa-
tion studies simply could not be attempted with
available markers. This situation has now changed
– the completion of the ﬁrst draft of the human
genome has spawned several large-scale SNP
discovery projects – we now have a wealth of SNP
data to facilitate these studies. Genetics is now
entering an exciting new era, where marker
resources and locus information are no longer the
main factors limiting the success of complex disease
gene hunting, the emphasis now lies on good study
design and the best possible study populations.
Likewise biologists will beneﬁt from this wealth of
data, with a more complete view of variation in
genes and regulatory regions.
A strong informatics infrastructure is critical to
effectively exploit this data. Databases need to
effectively integrate the array of newly generated
SNP data with pre-existing human mutation data
onto the framework of the human genome. Only
then will it be possible to construct sophisticated
SNP maps and take into account the full complex-
ity of human genetic variation that causes disease.
When is a SNP not a SNP?
Some deﬁnition of the term SNP is important for
this review. In the strictest sense a SNP is a single
base change, occurring at a frequency of >1%
– termed a polymorphism. When a single base
change occurs at <1% it is strictly considered to be
a mutation. This terminology is often disregarded,
many have suggested that ‘mutations’ occurring at
<1% in general populations should be termed low
frequency variants, whereas the term ‘Mutation’
implicitly suggests a variant with a deﬁned pheno-
type often inherited in a Mendelian manner.
Mutation databases and polymorphism databases
have generally been divided by this deﬁnition of
polymorphisms which are widespread in popula-
tions and mutations which are usually rare and are
not generally thought to occur widely in popula-
tions, but instead occur sporadically or are inher-
ited in a Mendelian manner. A grey area exists,
which argues against the rigidity of this division of
data (Figure 1). In a heterozygote form some
Mendelian mutations have been linked to complex
disease susceptibility and indeed are relatively
Figure 1. SNP and mutation databases on the Web
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zygote mutations in the cystathione beta synthase
gene cause homocystinuria, a rare disorder inducing
multiple strokes at an early age, the heterozygotes
do not share this severe disorder, but do have an
increased lifetime risk of stroke [7]. In Caucasians
the population frequency of homozygote homocys-
tinuria mutations, is only one per 126 000, but in
the same population, heterozygote frequency is
relatively high at one per 177. This illustrates the
point that it may not always be helpful to separate
polymorphism and mutation data, although clearly
both forms of data need to be well deﬁned.
SNP databases have progressed greatly in the last
year and we are now very close to the ultimate goal
of a comprehensive central SNP database, pre-
sented to the user in an integrated form across the
human genome. Mutation databases are lagging
considerably behind in terms of data integration
and visualisation and consequently most of this
potentially valuable mutation data is not readily
accessible to the biologist. The availability of a
complete draft of the human genome, ﬁnally presents
an opportunity to bring these two sources of data
together in a complete genomic context, without
compromising the integrity of either data collection.
Single nucleotide polymorphism (SNP)
databases
The deluge of SNP data generated over the past two
years can primarily be traced to two major sources:
The SNP consortium (TSC) [1] and members of the
human genome sequencing consortium, particularly
the Sanger Institute and Washington University.
The predominance of SNP data from this small
number of closely related sources has facilitated the
development of something very close to a central
SNP database – dbSNP at the NCBI [13]. Other
valuable databases have developed using this cen-
tral resource as a reference, these tools and data-
bases bring focus to speciﬁc subsets of SNP data,
eg., Gene orientated SNPs, while enabling further
data integration around dbSNP. A selection of
these tools and databases is summarised in Table 1.
dbSNP – a universal SNP database?
Established in September 1998, dbSNP currently
contains 3.9 million SNPs (Build 100 – Nov 2001).
These SNPs can be grouped into a non-redundant
set of 2.4 million SNPs, known as Reference SNPs
(RefSNPs). Approximately 10% of these RefSNPs
do not currently map to the draft human genome,
which leaves 2.16 million SNPs with immediate
utility for genetics. In the wake of the TSC and
other SNP discovery projects, further SNP submis-
sions will continue from the genome centres in the
ﬁnal stages of genome ﬁnishing, but dbSNP growth
is not likely to continue at the rates it has seen in
the past two years. Most journals now require SNP
submission to dbSNP before publication (a practice
which needs to be encouraged), these are estimated
to add to dbSNP at a rate of about 90 primarily
gene orientated SNPs per month. Based on the
observed SNP density in the genome, estimates
suggest that the dbSNP dataset may currently
represent 20–30% of SNPs in the human genome.
To clarify the scope of dbSNP, the database uses
‘SNP’ in the looser sense with no requirement or
assumption about minimum allele frequency, this
presents the intriguing possibility that some as yet
undetected disease causing mutations may exist in
dbSNP, although the vast majority are likely to be
polymorphisms of neutral effect. This is one of the
great challenges for genetics, now that we have our
snapshot of human genetic variation where lies the
disease?
Table 1. SNP and mutation databases and tools on
the web
Tool/Database URL
Mutation Databases
OMIM http://www.ncbi.nlm.nih.gov/Omim/
HGMD http://www.hgmd.org
GDB Mutation Waystation http://www.centralmutations.org/.
HUGO Mutation database
initiative
http://www.genomic.unimelb.edu.au/mdi/
Central SNP databases
dbSNP http://www.ncbi.nlm.nih.gov/SNP/
HGBase http://hgbase.cgr.ki.se/
Gene Orientated SNP
Visualisation
LocusLink http://www.ncbi.nlm.nih.gov/LocusLink/
PicSNP http://picsnp.org
CGAP http://lpgws.nci.nih.gov/
Tools for SNP visualisation and mapping
Ensembl http://www.ensembl.org
Golden Path Viewer http://genome.ucsc.edu/index.html
Map Viewer http://www.ncbi.nlm.nih.gov/cgi-bin/
Entrez/hum_srch
Genome Database (GDB) http://www.gdb.org
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The non-redundant reference SNP dataset in
dbSNP has been produced by clustering SNPs at
identical genomic positions and creating a single
representative SNP (designated by an ‘rs’ ID). This
data set considerably streamlines the process of
integrating SNPs with other data sources, so only
RefSNPs are mapped to external resources or
databases. RefSNPs are now closely integrated
with other NCBI databases, this has undoubtedly
been the key to dbSNP success, variation is now an
integral part of the NCBI data infrastructure, so
that the biologist can effortlessly browse to dbSNP
from diverse NCBI resources, including LocusLink,
Mapview and Genbank itself.
Searching dbSNP is possible in a number of
ways, including BLAST, text search or via other
NCBI tools, eg., LocusLink. Each RefSNP is quite
well characterised for the biologist, SNPs mapping
to genes are identiﬁed and localised to gene regions,
eg., introns, exons and promoter regions. Coding
SNPs are recorded and amino acid changes are
identiﬁed. Information derived from all members of
the cluster is collated, so for example allele
frequencies in more than one population source
may be available.
Candidate SNPs – SNP to assay
The dbSNP data set has one very signiﬁcant caveat.
SNPs generated by both the TSC and human
genome sequencing centres were essentially detected
by statistical methods to identify ‘candidate’ SNPs
by comparison of DNA sequence traces from
overlapping clones [8]. It is important to be aware
that these ‘candidate’ SNPs are mostly of unknown
frequency and are unconﬁrmed in a laboratory
assay, this translates to the simple fact that many
public SNPs are simply not real or more accurately
do not exist at a detectable frequency in a given
population. Marth et al. (2001) [9] investigated the
reliability of these candidate SNPs in some depth,
completing two pilot studies to determine how well
candidate SNPs would progress to working assays
in three common populations. In both studies, they
found that between 52–54% of the characterized
SNPs turn out to be common SNPs (above >10%)
for each population. Signiﬁcantly, between 30–34%
of the characterized SNPs were not detected in each
population. These results suggest that if a candidate
SNP is selected for study in a common population,
there is a 66–70% chance that the SNP will have
detectable minor allele frequency (1–5%) and a
50% chance that the SNP is common in that
population (>10%). Any genetic study needs to
take these levels of attrition between SNP and assay
into account (Table 2). There is only one solution to
this problem – to determine the frequency of the
two million or so public SNPs. This requirement is
now widely recognized in the SNP research com-
munity and several public groups are seeking to
establish large-scale SNP frequency determination
projects.
HGBASE
Although dbSNP is rapidly assuming the position
of the primary central SNP database, there is an
alternative central SNP database, HGBASE [3].
This database has expanded from its initial remit, as
a database of intra-genic sequence polymorphism –
to a whole genome polymorphism database.
HGBASE encompasses the same classes of variants
as dbSNP, indeed HGBASE is a signiﬁcant con-
tributor to dbSNP and both HGBASE and dbSNP
make regular data exchanges to allow data syn-
chronisation, however HGBASE has taken a dist-
inct approach by seeking to summarise all known
SNPs as a semi-validated, non-redundant set of
records.
HGBASE is seeking to address some of the
problems associated with candidate SNPs and so, in
contrast to the automated approach of dbSNP,
HGBASE is highly curated. The HGBASE curators
have carried out the valuable role of identifying
SNPs from the literature, particularly older pub-
lications before SNP database submission was the
norm. The curators are also striving to identify SNP
allele frequencies from the literature wherever
available and considerable efforts are made to
Table 2. Pitfalls from Candidate SNP to Assay (from
Marth et al., 2001)
SNP to Assay convertion steps
Remaining
RefSNPs
Reference SNP identiﬁed 2.4M
Not Mapped to Human Genome (10%) 2.16M
Assay design not possible or Assay Fails (15%) 1.84M
Not polymorphic in study population (17%) 1.52M
Frequency <20% in chosen population (50%) 1.26M
Common SNPs (>20% freq.) with assay available 0.63M
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consequences for coding regions, promoters and
splice sites. HGBASE currently contains 0.98M
human polymorphisms almost all of which are
represented in dbSNP (release 12 – Nov 2001).
Searching HGBASE is quite simple, tools are
available to facilitate BLAST searching and key-
word queries. HGBASE is aiming to provide a
more-highly validated SNP data set, by ﬁltering out
SNPs in repeat and low complexity regions and by
identifying SNPs for which a genotyping assay can
successfully be designed. This in silico quality
control approach may be valuable, particularly for
the broader community of consumers of SNP data,
for the geneticist, HGBASE serves to identify SNPs
with a much higher chance of converting from
‘candidate SNP’ to informative SNP assay. If you
take the cost of failed assays into account this is a
very valuable objective.
Tools for SNP visualisation – the genomic
context
A powerful alternative interface to public SNP data
is offered by the human genome. EnsEMBL and the
UCSC Golden Path viewer (Table 1) both maintain
current dbSNP and HGBASE annotation on the
human genome. User deﬁned queries place SNPs
into their full genomic context, giving very detailed
information on nearby genes, promoters or regions
conserved between species, including mouse and
ﬁsh. Comparative genome conservation may be
particularly useful for analysis of SNP functional
impact, as genome conservation is generally
thought to be restricted to gene or regulatory
regions and so this is one of the most powerful
tools for identifying potential regulatory regions or
undetected genes [2]. Figure 2 shows Ensembl
visualisation of SNPs in the promoter region and
ﬁrst exon of the PTEN oncogene, locus visualisa-
tion allows immediate assessment of the functional
context and conservation of each SNP.
Tools for SNP visualisation – the gene-
orientated context
For the biologist SNP information is generally of
most interest when located in genes or gene regions
– many tools are now available to visualise such
SNPs (Table 1). Almost all NCBI tools integrate
Figure 2. Ensembl visualisation of SNPs across the PTEN gene. Reproduced by permission of Ewan Birney
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is available, gene entries in LocusLink have a link
to a dbSNP RefSNP gene summary (a purple V or
VAR link). This summary details all SNPs across
the entire gene locus including upstream regions,
exons, introns and downstream regions. Non-
synonymous SNPs are identiﬁed and the amino
acid change is recorded, analysis even accommo-
dates splice variants.
Other tools are worth mentioning with different
approaches to the presentation of gene orientated
SNP data. PicSNP [4] is an interesting tool, which
presents a speciﬁc catalog of non-synonymous
SNPs in human genes. SNPs are further localised
to speciﬁc gene features, eg., swiss-prot annotated
domains, they are also sorted by the functional
ontology of genes, so for example it is possible to
identify all non-synonymous SNPs in genes with a
role in cell–cell signaling.
The CGAP database is also a valuable resource
which identiﬁes SNPs by in silico prediction from
alignments of ESTs, these can be viewed in a JAVA
assembly [11]. This information is captured by
dbSNP but it is also worthwhile searching CGAP
directly, as some potential SNPs which evade
detection by the automated SNP detection algo-
rithm can be identiﬁed by eye. The JAVA view of
trace data makes it possible to conﬁrm the base call
of a potential SNP in an EST.
Mutation databases
The polymorphism data stored in dbSNP is valu-
able information that helps to deﬁne the natural
range of variation in genes and the genome but
most of the polymorphisms might be assumed to be
functionally neutral. By contrast human gene
mutation data is functionally deﬁned and has
obvious implications for the nature and prevalence
of disease and the pathways underlying disease.
Many Mendelian disease mutations have been
identiﬁed since the early 70s and many highly
specialised locus speciﬁc databases (LSDBs) have
been established to collate this data. But in contrast
to SNP databases these disparate resources are
often unreliably maintained and vary greatly in
format and design, effectively making much of this
invaluable data unavailable to mainstream biology.
Several databases have been established to try to
address this situation although mutation data still
lacks a comprehensive central database and worse,
mutation data is still very poorly integrated with
other forms of biological data, particularly the
human genome. Hopefully some of the resources
below will change this situation.
The Human Gene Mutation Database (HGMD)
The HGMD was established in April 1996 to
collate published germline mutations responsible
for human inherited disease. In October 2001,
HGMD contained 23345 mutations in 2785 genes.
The scope of HGMD is limited to mutations
leading to a deﬁned inherited phenotype, including
a broad range of mechanisms, such as point
mutations, insertion/deletions, duplications and
repeat expansions within the coding regions of
genes. Recently, HGMD expanded its scope to
include disease-associated polymorphisms and so it
might be expected to share some overlap with SNP
databases. Somatic mutations and mutations in the
mitochondrial genome are not included. HGMD
invites submissions from researchers but most
records are curated directly from mutation reports
in more than 250 journals and directly from the
LSDBs which are comprehensively linked. To be
included, there must be a convincing association of
the mutation or polymorphism with the phenotype.
All mutations in HGMD are represented in a non-
redundant form, unfortunately this does not con-
serve all mutations constituting a cluster, so it is not
possible to determine if mutations are identical by
descent, also data is lost on the frequency of
mutations. The HGMD search interface is primarily
text based, targeted searching tends to rely on
knowledge of the correct HUGO nomenclature for
a gene.
HGMD contains valuable data, but it is difﬁcult
to avoid the feeling that this resource is not fully
exploiting its potential, genes are no longer the sole
point of reference, instead the whole genomic
context of genetic variation is increasingly import-
ant. No doubt in an attempt to address this,
HGMD has recently entered into a licensing
agreement with Celera genomics, providing Celera
with a period of exclusive access to new HGMD
data. Despite the obvious drawbacks of this agree-
ment for public users, it will undoubtedly enable
much needed development of the database. After
the period of exclusivity, the new, hopefully much
improved, HGMD database will be made publicly
available.
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OMIM is not strictly a mutation database, it is
more accurately an online catalog of human genes,
their associated genetic disorders and Mendelian
phenotypes with as yet unidentiﬁed genes, based on
the long running catalog Mendelian Inheritance in
Man (MIM), started in 1967 by Victor McKusick at
Johns Hopkins [6]. OMIM is an excellent source of
background biology on genes and diseases, it
includes information on the most common and
clinically signiﬁcant mutations and polymorphisms
in genes. Despite the name, OMIM also covers
complex diseases to varying degrees of detail. In
October 2001, the database contained over 13090
entries (including entries on 9658 gene loci and 954
phenotypes). OMIM is a manually curated digest of
the literature and consequently its entries may not
be current and they are not always comprehensive.
With this caveat aside it is a very valuable database,
with an added bonus of being well integrated with
the NCBI database family, this makes movement
from a disease to a gene to a locus and vice versa
fairly effortless. Unfortunately this integration stops
short of full sequence integration with human
genome viewers such as Ensembl, which is a
source of some frustration, but OMIM is never-
theless a highly recommended resource for muta-
tion related data.
The Genome database (GDB)
GDB is an ambitious genome database, which may
soon evolve into the long needed central mutation
database – but many difﬁculties have plagued its
development. GDB was established in 1990 as a
central repository for mapping information from
the human genome project. Throughout the early
90’s GDB was the dominant genome database and
served as the primary repository for genetic map
related information, but in January 98 after several
years of uncertain DOE funding, GDB funding was
ofﬁcially terminated. By December 98 funding from
another source was found, but at a signiﬁcantly
lower level. By this time other databases had
inevitably overtaken GDB as ‘central genome
databases’ [5]. Today GDB is still the most
comprehensive source of many forms of genetic
data, for example, tandem repeat polymorphisms (it
contains over 18000), it also contains extensive
information on fragile sites, deletions, disease genes
and mutations, collected by a mixture of curation
and direct submission. GDB development is
ongoing, the database’s historical focus on genetic
maps is broadening to a more integrated view of the
genome ultimately down to the sequence level
(which unfortunately is currently lacking). GDB
and the human genome organisation (HUGO) are
now planning a collaboration to establish federated
linkages with ‘boutique’ LSDBs by setting up a
‘Mutation Way Station’ to collect and disperse
mutations to LSDBs and central databases. This
will create a central mutation submission point to
provide a consistent interface and a standardised
format for all mutation data. After submission to
the Way Station an identiﬁer will be assigned and
the mutation will be redirected to the appropriate
LSDB as well as the central mutation database
maintained at GDB. This may be an important
strategic move, as the database already contains an
unprecedented range of genetic and genomic data,
plans to ﬁnally integrate a sequence map might well
make GDB a prominent resource again. But, this
strategy would not be without risks, GDB needs to
understand its own strengths and weaknesses, it
cannot cover everything. To position GDB as a
‘genomic database’ would be risky, Ensembl and
the UCSC are tough competition as genomic
databases, GDB’s strengths lie in genetics, so
perhaps GDB needs to reposition itself as a ‘genetic
database’ – it’s a move that wouldn’t even call for a
change in initials!
Conclusions
SNP discovery efforts and genome sequencing data
have yielded several million base positions that
might be polymorphic in the human genome. The
sheer scale of this data offers tremendous opportu-
nities for genetics and biology. But we are now
entering a new phase in genetics – the next step is to
relate genetic variation to disease. At this point the
distinction between polymorphism and mutation
data may become less distinct and integration will
become a more pressing issue. Human mutation
and polymorphism may simply be extremes of a
spectrum of disorders. Examples of rare mutations
such as homocystinuria mutations with a wider role
in complex disease already exist. The human
genome presents us with an ideal framework for
this data integration, by deﬁnition polymorphisms
and mutations are essentially sequence-based feat-
ures, and so the genome is an ideal template for this
data. As our understanding of the mechanisms of
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variation may become increasingly signiﬁcant.
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